Literature DB >> 9060707

Truncation of the human immunodeficiency virus type 1 envelope glycoprotein allows efficient pseudotyping of Moloney murine leukemia virus particles and gene transfer into CD4+ cells.

F Mammano1, F Salvatori, S Indraccolo, A De Rossi, L Chieco-Bianchi, H G Göttlinger.   

Abstract

Human immunodeficiency virus type 1 (HIV-1) can readily accept envelope (Env) glycoproteins from distantly related retroviruses. However, we previously showed that the HIV-1 Env glycoprotein complex is excluded even from particles formed by the Gag proteins of another lentivirus, visna virus, unless the matrix domain of the visna virus Gag polyprotein is replaced by that of HIV-1. We also showed that the integrity of the HIV-1 matrix domain is critical for the incorporation of wild-type HIV-1 Env protein but not for the incorporation of a truncated form which lacks the 144 C-terminal amino acids of the cytoplasmic domain of the transmembrane glycoprotein. We report here that the C-terminal truncation of the transmembrane glycoprotein also allows the efficient incorporation of HIV-1 Env proteins into viral particles formed by the Gag proteins of the widely divergent Moloney murine leukemia virus (Mo-MLV). Additionally, pseudotyping of a Mo-MLV-based vector with the truncated rather than the full-length HIV-1 Env allowed efficient transduction of human CD4+ cells. These results establish that Mo-MLV-based vectors can be used to target cells susceptible to infection by HIV-1.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9060707      PMCID: PMC191476     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  37 in total

Review 1.  Development of HIV vectors for anti-HIV gene therapy.

Authors:  E Poeschla; P Corbeau; F Wong-Staal
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-15       Impact factor: 11.205

2.  Isolation and properties of Moloney murine leukemia virus mutants: use of a rapid assay for release of virion reverse transcriptase.

Authors:  S Goff; P Traktman; D Baltimore
Journal:  J Virol       Date:  1981-04       Impact factor: 5.103

3.  Equine infectious anemia virus gag and pol genes: relatedness to visna and AIDS virus.

Authors:  R M Stephens; J W Casey; N R Rice
Journal:  Science       Date:  1986-02-07       Impact factor: 47.728

4.  Inducible human immunodeficiency virus type 1 packaging cell lines.

Authors:  H Yu; A B Rabson; M Kaul; Y Ron; J P Dougherty
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

5.  Incorporation of homologous and heterologous proteins into the envelope of Moloney murine leukemia virus.

Authors:  M Suomalainen; H Garoff
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

6.  Role of the matrix protein in the virion association of the human immunodeficiency virus type 1 envelope glycoprotein.

Authors:  T Dorfman; F Mammano; W A Haseltine; H G Göttlinger
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

7.  A human immunodeficiency virus type 1 (HIV-1)-based retroviral vector system utilizing stable HIV-1 packaging cell lines.

Authors:  R Carroll; J T Lin; E J Dacquel; J D Mosca; D S Burke; D C St Louis
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

8.  Virion incorporation of envelope glycoproteins with long but not short cytoplasmic tails is blocked by specific, single amino acid substitutions in the human immunodeficiency virus type 1 matrix.

Authors:  E O Freed; M A Martin
Journal:  J Virol       Date:  1995-03       Impact factor: 5.103

9.  Analysis in human immunodeficiency virus type 1 vectors of cis-acting sequences that affect gene transfer into human lymphocytes.

Authors:  C Parolin; T Dorfman; G Palú; H Göttlinger; J Sodroski
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

10.  Rescue of human immunodeficiency virus type 1 matrix protein mutants by envelope glycoproteins with short cytoplasmic domains.

Authors:  F Mammano; E Kondo; J Sodroski; A Bukovsky; H G Göttlinger
Journal:  J Virol       Date:  1995-06       Impact factor: 5.103

View more
  33 in total

1.  Identification of two sequences in the cytoplasmic tail of the human immunodeficiency virus type 1 envelope glycoprotein that inhibit cell surface expression.

Authors:  A Bültmann; W Muranyi; B Seed; J Haas
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

2.  Lipid rafts and pseudotyping.

Authors:  W F Pickl; F X Pimentel-Muiños; B Seed
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

3.  Intracellular trafficking of Gag and Env proteins and their interactions modulate pseudotyping of retroviruses.

Authors:  Virginie Sandrin; Delphine Muriaux; Jean-Luc Darlix; François-Loïc Cosset
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

4.  An envelope glycoprotein of the human endogenous retrovirus HERV-W is expressed in the human placenta and fuses cells expressing the type D mammalian retrovirus receptor.

Authors:  J L Blond; D Lavillette; V Cheynet; O Bouton; G Oriol; S Chapel-Fernandes; B Mandrand; F Mallet; F L Cosset
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

5.  Time-resolved imaging of HIV-1 Env-mediated lipid and content mixing between a single virion and cell membrane.

Authors:  Ruben M Markosyan; Fredric S Cohen; Grigory B Melikyan
Journal:  Mol Biol Cell       Date:  2005-09-29       Impact factor: 4.138

Review 6.  Molecular engineering of viral gene delivery vehicles.

Authors:  David V Schaffer; James T Koerber; Kwang-il Lim
Journal:  Annu Rev Biomed Eng       Date:  2008       Impact factor: 9.590

7.  Functional murine leukemia virus vectors pseudotyped with the visna virus envelope show expanded visna virus cell tropism.

Authors:  L Bruett; J E Clements
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

Review 8.  Library screening and receptor-directed targeting of gammaretroviral vectors.

Authors:  Peter M Mazari; Monica J Roth
Journal:  Future Microbiol       Date:  2013-01       Impact factor: 3.165

9.  Mutational analysis of the hydrophobic tail of the human immunodeficiency virus type 1 p6(Gag) protein produces a mutant that fails to package its envelope protein.

Authors:  D E Ott; E N Chertova; L K Busch; L V Coren; T D Gagliardi; D G Johnson
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

10.  Capsid is a dominant determinant of retrovirus infectivity in nondividing cells.

Authors:  Masahiro Yamashita; Michael Emerman
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.